Jove
Visualize
Contact Us

Related Concept Videos

Automated Microbial Diagnostics01:24

Automated Microbial Diagnostics

Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Importance of whole genome sequencing for the assessment of outbreaks in diagnostic laboratories: analysis of a case series of invasive Streptococcus pyogenes infections.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2017
Same author

[Publication of cross infection rate in surgical rooms: science and transparency].

Revue medicale suisse·2014
Same author

[Eosinophilia: from neoplastic disease to anguillulosis].

Revue medicale suisse·2014
Same author

[Microorganisms and us: who is in charge?].

Revue medicale suisse·2012
Same author

[Q fever: a cause of fever of unknown origin in Switzerland].

Revue medicale suisse·2012
Same author

[Infectious diseases: irrational and realistic uncertainties].

Revue medicale suisse·2010
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 4, 2026

High-throughput Detection Method for Influenza Virus
10:05

High-throughput Detection Method for Influenza Virus

Published on: February 4, 2012

[H1N1 (continued), multiresistant Enterobacteriacea, new diagnostic tools].

G Praz1

  • 1Service des maladies infectieuses, Institut central des hôpitaux valaisans, 1951 Sion. gerard.praz@hopitalvs.ch

Revue Medicale Suisse
|February 12, 2011
PubMed
Summary

The 2009 H1N1 pandemic concluded in 2010, prompting research into virus specificity and improved vaccine design. Concurrently, rising antibiotic resistance spurred a reevaluation of older drugs like fosfomycin and advancements in infectious disease diagnostics.

More Related Videos

Rapid Molecular Detection and Differentiation of Influenza Viruses A and B
05:38

Rapid Molecular Detection and Differentiation of Influenza Viruses A and B

Published on: January 30, 2017

Rapid and Specific Detection of Acinetobacter baumannii Infections Using a Recombinase Polymerase Amplification/Cas12a-based System
07:59

Rapid and Specific Detection of Acinetobacter baumannii Infections Using a Recombinase Polymerase Amplification/Cas12a-based System

Published on: April 25, 2025

Related Experiment Videos

Last Updated: Jun 4, 2026

High-throughput Detection Method for Influenza Virus
10:05

High-throughput Detection Method for Influenza Virus

Published on: February 4, 2012

Rapid Molecular Detection and Differentiation of Influenza Viruses A and B
05:38

Rapid Molecular Detection and Differentiation of Influenza Viruses A and B

Published on: January 30, 2017

Rapid and Specific Detection of Acinetobacter baumannii Infections Using a Recombinase Polymerase Amplification/Cas12a-based System
07:59

Rapid and Specific Detection of Acinetobacter baumannii Infections Using a Recombinase Polymerase Amplification/Cas12a-based System

Published on: April 25, 2025

Area of Science:

  • Virology
  • Infectious Diseases
  • Microbiology

Context:

  • The 2009 A(H1N1) influenza pandemic, declared over in October 2010, highlighted the need for effective vaccines.
  • Increasing antibiotic resistance, particularly in enterobacteria, necessitates the exploration of alternative treatments.
  • Significant progress in infectious disease diagnostics was observed in 2010.

Purpose:

  • To review publications on 2009 A(H1N1) virus specificity.
  • To explore novel approaches for designing more efficacious and accepted vaccines.
  • To discuss the resurgence of older antibiotics like fosfomycin in light of resistance patterns.
  • To highlight advancements in the diagnosis of infectious diseases.

Summary:

  • This review examines publications related to the 2009 A(H1N1) virus, focusing on its specificity and potential vaccine development strategies.
  • It addresses the growing challenge of antibiotic resistance, emphasizing the reevaluation of antibiotics such as fosfomycin.
  • The review also touches upon the diagnostic progress made in infectious diseases during 2010.

Impact:

  • Informs vaccine research and development for future pandemic preparedness.
  • Provides insights into antimicrobial stewardship and the potential role of older antibiotics.
  • Contributes to the understanding of diagnostic advancements in combating infectious diseases.